Mizuho Raises Elevance Health (ELV) PT to $413 Citing Peaking Healthcare Utilization Growth

Mizuho has increased its price target for Elevance Health (ELV) to $413, up from $400, while maintaining a 'Buy' rating. The upgrade is driven by Mizuho's belief that healthcare utilization growth, a key metric for health insurers, is stabilizing or peaking, which suggests a more predictable and potentially profitable environment for companies like Elevance Health.